The Role of Surgery in Small Cell Lung CarcinomaLimited Disease

Nídia Caires, Ana Rita Costa, Rita Carvalho, Vânia Caldeira, João Santos Silva, Dionísio Maia, João Eurico Reis, Sara Alfarroba, Rita Barata, Eugénia Pinto and Paulo Calvinho

Department of Pulmonology, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Portugal Department of Thoracic Surgery, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Portugal Department of Pathology, Hospital São José, Centro Hospitalar Universitário de Lisboa Central, Portugal

^*Correspondance to: Nídia Caires 

 PDF  Full Text Case Series | Open Access

Abstract:

Small cell lung carcinoma represents about 10% to 15% of all lung cancers. It exhibits an aggressive behavior and potential for early distant metastasis. Systemic chemotherapy with or without radiotherapy are the cornerstones of treatment in most patients with small cell lung carcinoma. However, in cases of limited stage disease and in selected patients, pulmonary resection surgery may be an option. In this study, we present three cases of small cell lung carcinoma that underwent pulmonary resection surgery in 2019, 2017 and 2015, respectively. At the time of writing, none of these patients presented recurrence of the disease.

Keywords:

Surgery; Limited disease; Small cell lung carcinoma

Cite the Article:

Caires N, Costa AR, Carvalho R, Caldeira V, Silva JS, Maia D. The Role of Surgery in Small Cell Lung Carcinoma-Limited Disease. Clin Oncol. 2020; 5: 1686.